Evidence map›Paper›PMID 38102671›Full record

ArticleBMC medicine2023

Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004-2020.

Melissa Min-Szu Yao, Vu Pham Thao Vy, Tony Hsiu-Hsi Chen, Hsian-He Hsu, Giu-Cheng Hsu, Cindy S Lee, Li-Ju Lin, Shu-Li Chia, Chao-Chun Wu, Wing P Chan and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 4 countries.

Melissa Min-Szu YaoDepartment of Radiology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, 112, Taiwan.
Vu Pham Thao VyInternational PhD Program of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Tony Hsiu-Hsi ChenInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, 100, Taiwan.
Hsian-He HsuDepartment of Radiology, Tri-Service General Hospital and National Defense Medical Center, Taipei, 11490, Taiwan.
Giu-Cheng HsuDepartment of Radiology, Kang-Ning General Hospital, Taipei, 114, Taiwan.
Cindy S LeeDepartment of Radiology, State University of New York, Stony Brook, NY, 11794, USA.
Li-Ju LinHealth Promotion Administration, Ministry of Health and Welfare, Taipei, 103, Taiwan.
Shu-Li ChiaHealth Promotion Administration, Ministry of Health and Welfare, Taipei, 103, Taiwan.
Chao-Chun WuHealth Promotion Administration, Ministry of Health and Welfare, Taipei, 103, Taiwan.
Wing P Chan *Department of Radiology, Wan Fang Hospital, Taipei Medical University, 111 Xinglong Road, Section 3, Taipei, 116, Taiwan. wingchan@tmu.edu.tw.ORCID 0000-0001-8322-6336
Amy Ming-Fang Yen *School of Oral Hygiene, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Ministry of Health and Welfare · KRIndustrial University of Ho Chi Minh City · VNKoo Foundation Sun Yat-Sen Cancer Center · TWNational Taiwan University · TWState University of New York · USTaipei Medical University · TWTaipei Medical University Hospital · TWTri-Service General Hospital · TWUniversity of Kang Ning · TW

Funding

Health Promotion Administration, Ministry of Health and Welfare A1011119Health Promotion Administration, Ministry of Health and Welfare A1021227Health Promotion Administration, Ministry of Health and Welfare A1031135Health Promotion Administration, Ministry of Health and Welfare A1041122Health Promotion Administration, Ministry of Health and Welfare A1051013Health Promotion Administration, Ministry of Health and Welfare A1061224
6 · The paper itself

Abstract

backgroundThe benefits of mammographic screening have been shown to include a decrease in mortality due to breast cancer. Taiwan's Breast Cancer Screening Program is a national screening program that has offered biennial mammographic breast cancer screening for women aged 50-69 years since 2004 and for those aged 45-69 years since 2009, with the implementation of mobile units in 2010. The purpose of this study was to compare the performance results of the program with changes in the previous (2004-2009) and latter (2010-2020) periods.

methodsA cohort of 3,665,078 women who underwent biennial breast cancer mammography screenings from 2004 to 2020 was conducted, and data were obtained from the Health Promotion Administration, Ministry of Health and Welfare of Taiwan. We compared the participation of screened women and survival rates from breast cancer in the earlier and latter periods across national breast cancer screening programs.

resultsAmong 3,665,078 women who underwent 8,169,869 examinations in the study population, the screened population increased from 3.9% in 2004 to 40% in 2019. The mean cancer detection rate was 4.76 and 4.08 cancers per 1000 screening mammograms in the earlier (2004-2009) and latter (2010-2020) periods, respectively. The 10-year survival rate increased from 89.68% in the early period to 97.33% in the latter period. The mean recall rate was 9.90% (95% CI: 9.83-9.97%) in the early period and decreased to 8.15% (95%CI, 8.13-8.17%) in the latter period.

conclusionsThe evolution of breast cancer screening in Taiwan has yielded favorable outcomes by increasing the screening population, increasing the 10-year survival rate, and reducing the recall rate through the participation of young women, the implementation of a mobile unit service and quality assurance program, thereby providing historical evidence to policy makers to plan future needs.

Indexed as

Breast NeoplasmsEarly Detection of CancerFemaleHumansMammographyMass ScreeningSurvival RateTaiwanAsiaBreast cancerMammographyScreeningSurvival rate

Identifiers

PMID38102671
PMCPMC10724902
OpenAlexW4389783218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.